Total Debt for AstraZeneca (AZN)
According to AstraZeneca's latest reported financial statements, the company's latest reported total debt is $29.70B USD. Total debt is the sum of short-term and long-term interest-bearing borrowings on the balance sheet (notes, bonds, term loans, lease liabilities). Useful for leverage and refinancing risk — combine with cash on hand for net debt, and see total liabilities for the broader obligations picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
AZN
Currently viewingRevenueSwitch metric
Latest period
$29.70B
YoY change
-1.4%
5Y CAGR
+7.8%
Peak year (2021)
$30.69B
Latest annual
$29.70B
Total Debt history chart for AstraZeneca (AZN) from 1990 to 2025
Total Debt history table for AstraZeneca (AZN) from 1990 to 2025
| Fiscal year | Period ended | Reported | Total Debt | YoY |
|---|---|---|---|---|
| 2025 | $29.70B | -1.4% | ||
| 2024 | $30.11B | +5.2% | ||
| 2023 | $28.62B | -1.8% | ||
| 2022 | $29.14B | -5.0% | ||
| 2021 | $30.69B | +50.6% | ||
| 2020 | $20.38B | +11.8% | ||
| 2019 | $18.23B | -4.6% | ||
| 2018 | $19.11B | +7.3% | ||
| 2017 | $17.81B | +5.9% | ||
| 2016 | $16.81B | +11.7% | ||
| 2015 | $15.05B | +38.8% | ||
| 2014 | $10.84B | +4.5% | ||
| 2013 | $10.38B | +0.6% | ||
| 2012 | $10.31B | +10.5% | ||
| 2011 | $9.33B | -2.8% | ||
| 2010 | $9.60B | -15.1% | ||
| 2009 | $11.31B | -4.6% | ||
| 2008 | $11.85B | -21.8% | ||
| 2007 | $15.16B | +1139.2% | ||
| 2006 | $1.22B | +1.8% | ||
| 2005 | $1.20B | -5.4% | ||
| 2004 | $1.27B | +178.9% | ||
| 2003 | $455.00M | -46.1% | ||
| 2002 | $844.00M | -38.3% | ||
| 2001 | $1.37B | +61.9% | ||
| 2000 | $845.38M | -24.4% | ||
| 1999 | $1.12B | +7.3% | ||
| 1998 | $1.04B | -11.1% | ||
| 1997 | $1.17B | -5.7% | ||
| 1996 | $1.24B | -2.0% | ||
| 1995 | $1.27B | +8.5% | ||
| 1994 | $1.17B | -36.6% | ||
| 1993 | $1.84B | -46.8% | ||
| 1992 | $3.47B | +1.2% | ||
| 1991 | $3.43B | -1.5% | ||
| 1990 | $3.48B | — |
Total Debt values are taken from AstraZeneca's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, AstraZeneca (AZN) total debt totalled $29.70B – edged down 1.4% year-over-year.
Across 2020–2025 (5 years), AstraZeneca total debt produced a CAGR of +7.8% – with the latest reading among the more recent periods of the dataset.
2021 marks the peak total debt at $30.69B, with the historical low of $455.00M recorded in 2003.
AstraZeneca (AZN) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $52.57B.
AstraZeneca Total Debt by Year
AstraZeneca Total Debt 2025: $29.70B
AstraZeneca total debt in 2025 was $29.70B, edged down 1.4% below 2024.
AstraZeneca Total Debt 2024: $30.11B
AstraZeneca total debt in 2024 was $30.11B, grew 5.2% from 2023.
AstraZeneca Total Debt 2023: $28.62B
AstraZeneca total debt in 2023 was $28.62B, edged down 1.8% below 2022.
AstraZeneca Total Debt 2022: $29.14B
AstraZeneca total debt in 2022 was $29.14B, declined 5.0% below 2021.
AstraZeneca Total Debt 2021: $30.69B
AstraZeneca total debt in 2021 was $30.69B.
See more financial history for AstraZeneca (AZN).
Sector peers — Total Debt
Companies in the same sector as AstraZeneca, ranked by their latest total debt.
| Company | Total Debt | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $130.96B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $78.39B | Healthcare |
| AbbVie Inc. (ABBV) | $69.07B | Healthcare |
| Amgen Inc. (AMGN) | $54.60B | Healthcare |
| Merck & Co., Inc. (MRK) | $50.53B | Healthcare |
| Johnson & Johnson (JNJ) | $47.93B | Healthcare |
| Eli Lilly and Company (LLY) | $42.50B | Healthcare |
| Thermo Fisher Scientific Inc. (TMO) | $40.85B | Healthcare |
Frequently asked questions
What is AstraZeneca's total debt?
- Latest reported total debt for AstraZeneca (AZN) is $29.70B (period ending December 31, 2025).
How has AstraZeneca total debt changed year-over-year?
- AstraZeneca (AZN) total debt changed -1.4% year-over-year on the latest annual filing.
What is the long-term growth rate of AstraZeneca total debt?
- AstraZeneca (AZN) total debt compound annual growth rate is +7.8% over the most recent 5 years available.
When did AstraZeneca total debt hit its highest annual value?
- AstraZeneca total debt reached its highest annual value of $30.69B in 2021.
What was AstraZeneca total debt in 2024?
- AstraZeneca (AZN) total debt in 2024 was $30.11B.
What was AstraZeneca total debt in 2025?
- AstraZeneca (AZN) total debt in 2025 was $29.70B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
AZN Overview
Company profile, financial tools, and key metrics
AZN Revenue Counter
Earns $1,863 every second. See per minute, hour, and day.
AZN Earnings Counter
Earns $324.23 per second net profit. See per minute, hour, and day.
AZN Economic Scale
Exceeds Bolivia's GDP. Compare with world economies.
AZN What If Invested
What if you had invested $1,000? See historical returns from any date.
AZN How It Makes Money
Discover visual breakdown of $58.74B in revenue — where it comes from and where it goes.
AZN Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
AZN Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
AZN Daily Price Character
Steady · 49.4% historical win rate (green days). Streaks & record days.
AZN Buybacks
0.16% TTM buyback yield. Shareholder yield & SBC comparison.
AZN Stock Split History
3 splits on record. Dates, ratios, and cumulative multiple.
AZN Dividend Profile
Yield: 1.73%. Safety: 6/8. See full history.
AZN Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
AZN Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.